Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
+10.2M
-
Total reported value, excl. options
-
$421M
-
Value change
-
+$143M
-
Put/Call ratio
-
0.65
-
Number of buys
-
110
-
Number of sells
-
-48
-
Price
-
$12.32
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q2 2025
191 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q2 2025.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 78.8M outstanding shares and own 43.35% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.36M shares), VANGUARD GROUP INC (4.33M shares), MARSHALL WACE, LLP (2.58M shares), CITADEL ADVISORS LLC (1.71M shares), STATE STREET CORP (1.6M shares), GEODE CAPITAL MANAGEMENT, LLC (1.6M shares), Nuveen, LLC (1.47M shares), MORGAN STANLEY (767K shares), Ghisallo Capital Management LLC (750K shares), and Alyeska Investment Group, L.P. (750K shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.